In this study we aimed to define the protein and viral subtype specificities of helper Th cells to respiratory syncytial virus (RSV). BALB/c mice were primed by infection with RSV, or with vaccinia viruses (VV) containing genes encoding several individual RSV proteins. Priming for Th cell memory was assayed by stimulating spleen cells in vitro with different RSV isolates and measuring RSV-specific interleukin 2 (IL-2) release by T cells into supernatants using an IL-2-dependent CTLL cell line. Splenocytes from mice primed intranasally with RSV exhibited RSV-specific Th cell memory, whereas those from unprimed mice did not. Th cell recognition was in part specific to the strain of RSV used in priming and in part cross-reactive between RSV strains. Intraperitoneal priming with RSV fusion protein-expressing VV or nucleoprotein-expressing VV induced a stronger RSV-specific Th cell response than the attachment glycoprotein-expressing VV which produced only slight Th recognition. No Th cell recognition of two non-structural proteins (1A and 1B) could be demonstrated.
BALLL. A., YOUNGK. K. Y., ANDERSONK., COLLINSP. L., WERTZG.1986; Expression of the major glycoprotein G of human respiratory syncytial virus from recombinant vaccinia virus vectors. Proceedings of the National Academy of Sciences, U.S.A 83:246–250
BANGHAMC. R. M., ASKONASB. A.1986; Murine cytotoxic T cells specific to respiratory syncytial virus recognize different antigenic subtypes of the virus. Journal of General Virology 67:623–629
BANGHAMC. R. M., McMLCHAELA. J.1986; Specific human cytotoxic T cells recognize B cell lines persistently infected with respiratory syncytial virus. Proceedings of the National Academy of Sciences, U.S.A 83:9183–9187
BANGHAMC. R. M., CANNONM. J., KARZOND. T., ASKONASB. A.1985; Cytotoxic T-cell response to respiratory syncytial virus in mice. Journal of Virology 56:55–59
BANGHAMC. R. M., OPENSHAWP. J. M., BALLL. A., KINGA. M. Q., WERTZG. W., ASKONASB. A.1986; Human and murine cytotoxic T cells specific to respiratory syncytial virus recognise the viral nucleoprotein (N), but not the major glycoprotein (G) expressed by vaccinia virus recombinants. Journal of Immunology 137:3973–3977
CANNONM. J.1987; Microplaque immunoperoxidase detection of infectious respiratory syncytial virus in the lungs of infected mice. Journal of Virological Methods 16:293–301
CANNONM. J., STOTTE. J., TAYLORG., ASKONASB. A.1987; Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells. Immunology 62:133–138
CHANOCKR. M., KAPIKIANA. Z., MILLSJ., KIMH. W., PARROTTR. H.1970; Influence of immunological factors in respiratory syncytial virus disease. Archives of Environmental Health 21:347–356
COBBOLDS. P., JAYASURIYAA., NASHA., PROSPEROT. D., WALDMANNN.1984; Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature, London 312:548
ELANGON., PRINCEG. A., MURPHYB. R., VENKATESANR. M., CHANOCKR. M., MOSSB.1986; Resistance to human respiratory syncytial virus infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein. Proceedings of the National Academy of Sciences, U.S.A 83:1906
FISHAUTM., TUBERGEND., McINTOSHK.1980; Cellular response to respiratory viruses with particular reference to children with disorders of cell mediated immunity. Journal of Pediatrics 96:179–186
FULGINITIV. A., ELLERJ. J., SIEBERO. F., JOYNERJ. W., MINAMITANIM., MEIKLEJOHNG.1969; Respiratory virus immunisation. I. A field trial of two inactivated respiratory virus vaccines: an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. American Journal of Epidemiology 89:435–448
GOTTLIEBP. D., MARSHAK-ROTHSTEINA., AUDITORE-HARGRAVESK., BERKOBEND. B., AUGUSTD. A., ROSCHER. M., BENEDETTOJ. D.1980; Construction and properties of new Lyt-congenic strains and anti-Lyt 2.2 andanti-Lyt 3.1 monoclonal antibodies. Immunogenetics 10:545
GRUBERC., LEVINES.1985; Respiratory syncytial virus polypeptides. IV. The oligosaccharides of the glycoproteins. Journal of General Virology 66:417–432
HALLC. B., POWELLK. R., MacDONALDN. E., GALAC. L., MENEGUSM. E., SUFFINS. C., COHENH. J.1986; Respiratory syncytial viral infection in children with compromised immune function. New England Journal of Medicine 315:77–81
HENDRICKSD. A., BARADARANK., McINTOSHK., PATTERSONJ. L.1987; Appearance of a soluble form of the G protein of respiratory syncytial virus in the fluids of infected cells. Journal of General Virology 68:1705–1714
KIMH. W., CANCHOLAJ. G., BRANDTC. D., PYLESG., CHANOCKR. M., JENSENK., PARROTTR. H.1969; Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. American Journal of Epidemiology 89:422–434
KIMH. W., ARROBIOJ. O., BRANDTC. D., JEFFERIESB. C, PYLESG., REIDI. L., CHANOCKR. M., PARROTTR. H.1973; Epidemiology of respiratory syncytial virus infection in Washington D.C. I. importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. American Journal of Epidemiology 98:216–225
KIMH. W., LEIKINS. L., ARROBIOJ. O., BRANDTC. D., CHANOCKR. M., PARROTTR. H.1980; Cell mediated immunity to respiratory syncytial virus induced by inactivated vaccine or by infection. Pediatric Research 10:75–78
OLMSTEDR. A., ELANGON., PRINCEG. A., MURPHYB. R., JOHNSONP. R., MOSSB., CHANOCKR. M., COLLINSP. L.1986; Expression of the F glycoprotein in respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proceedings of the National Academy of Sciences, U.S.A 83:7462–7466
PARROTTR. H., KIMW. H., ARROBIOJ. O., HODESD. S., MURPHYB. R., BRANDTC. D., CAMARGOE., CHANOCKR. M.1973; Epidemiology of respiratory syncytial virus infection in Washington D.C. II. Infection and disease with respect to age, immunologic status, race and sex. American Journal of Epidemiology 98:289–300
PEMBERTONR. M., CANNONM. J., OPENSHAWP. J. M., BALLL. A., WERTZG. W., ASKONASB. A.1987; Cytotoxic T cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen. Journal of General Virology 68:2177–2182
PRINCEG. A., HORSWOODR. L., CAMARGOE., KOENIGD., CHANOCKR. M.1983; Mechanisms of immunity to respiratory syncytial virus in cotton rats. Infection and Immunity 42:81–87
PRINCEG. A., HORSWOODR. L., CHANOCKR. M.1985; Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats. Journal of Virology 55:517–520
SCHERLEP. A., GERHARDW.1986; Function analysis of influenza-specific helper T cell clones in vivo: T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin. Journal of Experimental Medicine 164:1114–1128
STOTTE. J., BALLL. A., YOUNGK. K., FURZEJ., WERTZG. W.1986; Human respiratory syncytial virus glycoprotein G expressed from recombinant vaccinia virus vector protects mice against live virus challenge. Journal of Virology 60:607–613
WAGNERD. K., BARNEYS. G., WRIGHTP. F., WALSHE. E., KIMH. W., REIMERC. B., NELSOND. L., CHANOCKR. M., MURPHYB. R.1986; Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection. Journal of Clinical Microbiology 24:304–306
WARDK. A., LAMBDENP. R., OGLLVIEM. M., WATTP. J.1983; Antibodies to respiratory syncytial virus polypeptides and their significance in human infection. Journal of General Virology 64:1867–1876
WEBBM. S. C, HENRYR. L., MILNERA. D., STOKESG. M., SWARBRICKA. S.1985; Continuing problems three and a half years after acute viral bronchiolitis. Archives of Disease in Childhood 60:1064–1067
WERTZG. W., COLLINSP. L., HUANGY., GRUBERC, LEVINES., BALLL. A.1985; Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein. Proceedings of the National Academy of Sciences, U.S.A 82:4075–4079
WERTZG. W., STOTTE. J., YOUNGK. K. J., ANDERSONK., BALLL. A.1987; Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccinia virus vectors and protection of vaccinated mice. Journal of Virology 61:293–301
WRIGHTP. F., BELSHER. B., KIML. P., VAN VORKL. P., CHANOCKR. M.1982; Administration of a highly attenuated live respiratory syncytial virus vaccine to adults and children. Infection and Immunity 37:397–400